Monthly News Letters

Greetings from Trials360! As we reflect on our anniversary and the past year, we are filled with gratitude and pride in the remarkable strides we have made together. Despite the challenges we faced, our team at Trials360 has achieved significant milestones that have further solidified our position as a leader in the pre-clinical and clinical […]

Trials360 Achieves Milestone in Phase 2b Clinical Trial for Acute Stroke Patients Acute stroke and intracerebral hemorrhages represent some of the most common admissions in neurological intensive care units. Effective management of these conditions is crucial for achieving better patient outcomes and alleviating the substantial burden on families and society. One critical aspect of this

Trials360 Developed Stroke Rat Model Description: Greetings from the Trials 360 monthly newsletter! We are thrilled to announce another milestone at Trials 360: The successful development of a Stroke Rat Model through Common Carotid Artery Occlusion (CCAO). This achievement holds significant importance in medical research, particularly in the study of Ischemic Stroke, a major global

Trials360 Developed ALI Rat Model Description: Trials 360 is excited to announce the development of an in-house Acute Lung Injury (ALI) rat model for studying pulmonary diseases. The model’s validation tests included X-ray, CBC (Complete Blood Count), ESR (Erythrocyte Sedimentation Rate), ELISA-IL 6, Wet & Dry weigh, and histopathology. This model provides a robust platform